Is the B&M recovery underway?

B&M European Value Retail (LSE:BME) reported an encouraging sales rebound, with UK total sales, including new space, up approximately 9% year-on-year for the first 11 weeks of Q1, exceeding analyst forecasts. This acceleration, driven by strong seasonal and garden categories and new store openings, signals a potential return to positive like-for-like growth and a margin-favorable shift as general merchandise outperforms grocery. Shares rose 1.2% on the news, as investors anticipate confirmation of a firmer growth trajectory.

Analysis

B&M European Value Retail is demonstrating a significant sales rebound in its first quarter, with preliminary till roll data analyzed by Citi indicating total UK sales growth of approximately 9% year-on-year for the initial 11 weeks. This performance surpasses Citi's own 8.4% forecast and the 6.9% consensus estimate from Visible Alpha, signaling potential upside. The growth momentum has notably accelerated, reaching 10% year-on-year in the most recent four-week period to June 15, an 8.5 percentage point increase over the prior four weeks. This improvement is attributed to strong performance in seasonal and garden categories, aided by favorable weather and the contribution from new store openings. Critically for profitability, the outperformance of higher-margin general merchandise compared to grocery suggests a favorable mix shift that could benefit margins. While Citi remains cautious, citing historical inaccuracies with the data source, the positive trends have prompted a 1.2% increase in B&M's shares as investors now focus on the company's official trading update for confirmation of a sustained recovery.

Key Decisions for Investors

• Given the sales beat against forecasts and a margin-accretive product mix, investors could consider the potential for a positive earnings surprise in the upcoming Q1 update.
• It is crucial to monitor the official company announcement to validate this preliminary data, as a failure to confirm these trends would negate the current positive thesis.
• The relatively muted 1.2% share price increase on this strong but unconfirmed data may present a tactical opportunity for investors bullish on the UK consumer recovery story ahead of the official report.